NASDAQ · ALGN
Healthcare · Medical - Devices
$153.29
Down-$5.12 (-3.34%)
Updated Sep 24, 2026, 12:08 AM
SID Score
5.3/10
Composite research score
Smart Money
57/100
Neutral
Price performance
1M range · 19 trading sessions · Daily adjusted prices
ALGN closed at $153.29 after 19 trading sessions, down 3.68% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 22, 2026 | $149.17 | $154.10 | $147.615 | $153.29 | 967K |
| Sep 21, 2026 | $147.97 | $148.37 | $145.55 | $146.88 | 975.82K |
| Sep 18, 2026 | $149.52 | $150.78 | $146.20 | $147.61 | 1.5M |
| Sep 17, 2026 | $151.21 | $152.105 | $148.98 | $149.71 | 796.01K |
| Sep 16, 2026 | $148.18 | $152.46 | $147.56 | $150.45 | 946.51K |
| Sep 15, 2026 | $151.46 | $152.49 | $146.82 | $147.00 | 1.03M |
| Sep 14, 2026 | $151.29 | $153.86 | $150.67 | $153.00 | 718.59K |
| Sep 11, 2026 | $153.30 | $153.87 | $149.49 | $150.82 | 619.85K |
| Sep 10, 2026 | $150.55 | $151.22 | $148.50 | $150.72 | 836.08K |
| Sep 9, 2026 | $152.54 | $153.875 | $151.315 | $152.92 | 1.11M |
| Sep 8, 2026 | $156.13 | $156.13 | $153.14 | $153.49 | 807.21K |
| Sep 4, 2026 | $157.67 | $160.495 | $155.24 | $158.635 | 990.52K |
| Sep 3, 2026 | $159.65 | $162.915 | $155.8401 | $159.855 | 694.15K |
| Sep 2, 2026 | $155.50 | $160.85 | $155.50 | $159.15 | 687.06K |
| Sep 1, 2026 | $158.21 | $159.33 | $153.98 | $154.96 | 576.46K |
| Aug 31, 2026 | $155.36 | $160.48 | $154.50 | $159.79 | 1.29M |
| Aug 28, 2026 | $158.51 | $159.965 | $157.21 | $157.58 | 954.65K |
| Aug 27, 2026 | $157.80 | $162.09 | $157.77 | $158.84 | 801.29K |
| Aug 26, 2026 | $158.85 | $161.66 | $158.53 | $159.14 | 653.66K |
The latest Smart Investors Daily articles mentioning ALGN.
ALGN research
Company profile and research snapshot.
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Jul 9, 2026 | BMO Capital | Outperform | — |
| Apr 30, 2026 | Evercore ISI Group | Outperform | — |
| Apr 24, 2026 | Morgan Stanley | Equal-Weight | — |
| Apr 21, 2026 | Piper Sandler | Overweight | — |
| Apr 15, 2026 | Citigroup | Buy | — |
No generated briefing is available yet.
Yahoo · Sep 18, 2026
Align Technology has lagged the broader market over the past year, even as Wall Street analysts remain cautiously optimistic about the company’s future prospects.
Yahoo · Sep 18, 2026
Align Technology (NASDAQ:ALGN) sees continued growth potential for Invisalign clear aligners in the United States and internationally despite a challenging consumer environment, Chief Financial Officer John Morici said during a Baird investor conference. Morici said inflation and patient reluctance
SeekingAlpha · Sep 15, 2026
Align Technology, Inc. (ALGN) 2026 Global Healthcare Conference September 15, 2026 3:10 PM EDTCompany ParticipantsJohn Morici - CFO & Executive VP of...
Yahoo · Sep 15, 2026
The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant challenges, whether it’s stagnating growth, heavy debt, or disruptive new competitors.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning ALGN.
